Display options:
AAA
Follow us on: Follow us on Twitter|

Oxford University Hospitals NHS Trust|

Oxford University Hospitals NHS Trust|

 
   

Share this page on these sites

Lymphoma and Leukaemia Diagnosis

Diagnostics

State-of-the-art diagnosis of haematological malignancies includes morphology and haematopathology, immunophenotyping and immunohistochemistry, cytogenetics and molecular genetics. Samples arrive in one central specimen reception and are treated according to defined algorithms in order to avoid test duplication. Results obtained by each approach are integrated into one single overall diagnosis and presented for discussion to the multidisciplinary tumour site specific group meetings. The aim is to increase speed and precision of diagnosis and to avoid unnecessary or inappropriate treatments.

Oxford BRC translational research

The laboratory aims to be actively involved in translational research.

It provides samples for ethically approved research projects and works closely with the Oxford Biobank. It supports clinical trials and biological studies through full characterization of clinical samples and minimal residual disease monitoring. It translates and validates new technologies and it is currently developing its own focus of research into leukaemia propagating cells in B-cell chronic lymphocytic leukaemia.

5.1 AML

5.2 CLL

5.3 CML

5.4 ALL

5.5 NHL